Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth A Mittendorf, MD,FACS
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
197 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Onco Hospital
Plovdiv, Bulgaria
- Serdika
Sofia, Bulgaria
- Tsaritsa Yoanna - Isul
Sofia, Bulgaria
- Sveta Marina
Varna, Bulgaria
- Complex Oncology Center, Veliko Tarnovo
Veliko Tarnovo, Bulgaria
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Health Sciences North Cancer Centre
Greater Sudbury, Ontario, Canada
- Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
- Sunnybrook Research Institute
Toronto, Ontario, Canada
- Hospital Charles Lemorne
Greenfield Park, Quebec, Canada
- Masaryk Memorial Cancer Institute, Comprehensive Cancer Care Clinic
Brno, Czechia
- University Hospital Hradec Kralove, Clinic of Oncology and Radiotherapy
Hradec Králové, Czechia
- University Hospital Olomouc, Clinic of Oncology
Olomouc, Czechia
- General University Hospital in Prague, Clinic of Oncology
Prague, Czechia
- Institut de Cancérologie de L'Ouest Siet Paul Papin
Angers, Cedex 9, France
- Centre Oscar Lambret
Cédex, Lille, France
- Institut de Cancérologie de L'Ouest/rené Gauducheau
Saint Herblain, Nantes Cedex, Loire-Atlantique, France
- Centre Antoine Lacassagne
Nice, France
- Charité Campus Mitte Universitaetsmedizin-Berlin Brustzentrum/studienzentrum
Berlin, Germany
- Brustzentrum Klinikum Bremen-Mitte Ggmbh
Bremen, Germany
- Universitätsklinikum Erlangen, Frauenklinik
Erlangen, Germany
- Kliniken Essen Mitte, Evang. Huyssens Stiftung/knappschaft Gmbh, Klinik Für Senologie/brustzentrum
Essen, Germany
- Universitätsklinikum Frankfurt, Klinik Für Frauenheilkunde Und Geburtshilfe
Frankfurt, Germany
- Nationales Centrum Für Tumorerkrankungen (nct), Gynäkologische Onkologie
Heidelberg, Germany
- Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, Germany
- Universität Marburg
Marburg, Germany
- Rotkreuzklinikum München Ggmbh, Frauenklinik
München, Germany
- Universitätsklinikum Münster, Klinik Und Poliklinik Für Frauenheilkunde Und Geburtshilfe
Münster, Germany
- Klinikum Stuttgart, Krankenhaus Bad Cannstatt, Frauenklinik
Stuttgart, Germany
- Klinikum Mutterhaus Der Borromaeerinnen
Trier, Germany
- Gemeinschaftspraxis Für Innere Medizin, Haematologie Und Internistische Onkologie Dr. R Schlag/dr. Schoettker
Würzburg, Germany
- Hetenyi Geza Hospital, Department of Oncology
Szolnok, Jász-Nagykun-Szolnok, Hungary
- Semmelweis University, Department of Diagnostic Radiology and Oncotherapy
Budapest, Hungary
- Szent Margit Hospital, V. Department of Internal Medicine, Oncology
Budapest, Hungary
- Petz Aladar County Teaching Hospital, Center for Oncoradiology
Győr, Hungary
- Kaposi Mor County Teaching Hospital, Center for Clinical Oncology
Kaposvár, Hungary
- Borsod-Abauj-Zemplen County Hospital and University Educational Hospital, Center for Clinical Oncology and Radiology
Miskolc, Hungary
- Rambam Health Care Campus
Haifa, Haifa District, Israel
- Sheba Medical Centre
Tel Hasomer, Ramat Gan, Israel
- Rabin Medical Centre
Petah Tikva, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 21 Sept 2016
- Completion
- 21 Sept 2016
- Last update posted
- 27 Feb 2017
- Registered enrollment
- 758
- Registry id
- NCT01479244
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.